ctrl K

SQZ Biotechnologies (SQZ)

NYSE: SQZ · Real-Time Price · USD

0.43

0.16 (59.26%)

At close: Jul 03, 2023, 5:00 PM

SQZ Biotechnologies Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	21.03M	27.1M	21M	19.32M	12.67M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a
Gross Profit	21.03M	27.1M	21M	19.32M	12.67M
Operating Income	-80.68M	-68.77M	-51.06M	-34.27M	-20.4M
Interest Income	1.22M	36K	550K	2.07M	978K
Pretax Income	-79.46M	-68.74M	-50.52M	-32.2M	-19.25M
Net Income	-78.24M	-68.7M	-49.97M	-32.2M	-19.25M
Selling & General & Admin	26.32M	25.72M	20.51M	18.27M	8.69M
Research & Development	70.98M	70.15M	51.55M	36.1M	24.38M
Other Expenses	-449K	-8K	-13K	-791K	-1.13M
Operating Expenses	96.85M	95.87M	72.06M	53.58M	31.94M
Interest Expense	9.72M	n/a	n/a	n/a	59K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	96.85M	95.87M	72.06M	53.58M	33.07M
Income Tax Expense	-1.22M	-36K	-550K	-7K	1.21M
Shares Outstanding (Basic)	28.81M	27.58M	5.4M	17.92M	14.41M
Shares Outstanding (Diluted)	28.81M	27.58M	5.4M	17.92M	14.41M
EPS (Basic)	-2.72	-2.49	-9.25	-1.8	-1.34
EPS (Diluted)	-2.72	-2.49	-9.25	-1.8	-1.34
EBITDA	-59.28M	-57.74M	-40.12M	-27.85M	-18.12M
EBIT	-69.75M	n/a	n/a	n/a	-19.19M
Depreciation & Amortization	21.4M	11.03M	10.94M	6.42M	1.07M